Prepare For A Second Wave With These 5 Undervalued Low-Risk Dividend AristocratsSeeking Alpha • 06/16/20
VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia PatientsPRNewsWire • 06/13/20
AbbVie Presents New Late-Breaking Data Showing SKYRIZI® (risankizumab-rzaa) Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® (secukinumab) at 52 WeeksPRNewsWire • 06/12/20
AbbVie Jumped Into The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?Investors Business Daily • 06/12/20
3 Wins for AbbVie in 3 Days Provide 3 More Good Reasons to Buy the Pharma StockThe Motley Fool • 06/11/20
AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the OriginalThe Motley Fool • 06/10/20
Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid ArthritisPRNewsWire • 06/10/20
Genmab's stock surges after drug development deal with AbbView valued at up to nearly $4 billionMarket Watch • 06/10/20